• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖类抗原19-9检测在健康人群中的效用以及糖类抗原19-9水平升高个体进行医学随访的必要性。

Usefulness of Carbohydrate Antigen 19-9 Test in Healthy People and Necessity of Medical Follow-up in Individuals with Elevated Carbohydrate Antigen 19-9 Level.

作者信息

Lee Sang Pyo, Sung In-Kyung, Kim Jeong Hwan, Lee Sun-Young, Park Hyung Seok, Shim Chan Sup

机构信息

Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.

Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.

出版信息

Korean J Fam Med. 2019 Sep;40(5):314-322. doi: 10.4082/kjfm.18.0057. Epub 2019 Apr 8.

DOI:10.4082/kjfm.18.0057
PMID:30959581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6768838/
Abstract

BACKGROUND

Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker whose level is elevated in many types of cancers and other benign conditions. CA 19-9 levels are frequently found to be elevated in individuals during general health examinations. This study aimed to investigate the clinical characteristics of such individuals and to determine the need for medical follow-up.

METHODS

We investigated individuals who underwent a health inspection, including a serum CA 19-9 test, at our center. Their CA 19-9 levels, age, sex, body mass index (BMI), and personal and past histories were investigated. Additionally, subgroup analyses were performed for those who underwent follow-up study for the elevated CA 19-9 levels.

RESULTS

Of 58,498 subjects, 581 (1.0%) had elevated CA 19-9 levels. Multivariate analyses revealed that older age, female sex, lower BMI, and diabetes were independent predisposing factors for elevated CA 19-9 level. A subgroup analysis revealed that the causative conditions were identified in 129 of 351 subjects (36.8%). Among them, the causative conditions in 31 subjects (8.8%, including four cases of cancer and 15 of benign tumors) were not detected at the initial check-up and were found during the follow-up period.

CONCLUSION

The use of CA 19-9 as a marker for cancer in healthy individuals is inappropriate. However, medical follow-up in individuals with elevated CA 19-9 levels may be useful because some causative diseases may be detected during follow-up.

摘要

背景

糖类抗原19-9(CA 19-9)是一种肿瘤标志物,其水平在多种癌症及其他良性疾病中会升高。在一般健康检查中,经常发现个体的CA 19-9水平升高。本研究旨在调查此类个体的临床特征,并确定是否需要医学随访。

方法

我们调查了在本中心接受包括血清CA 19-9检测在内的健康检查的个体。调查了他们的CA 19-9水平、年龄、性别、体重指数(BMI)以及个人史和既往史。此外,对CA 19-9水平升高并接受随访研究的个体进行了亚组分析。

结果

在58498名受试者中,581名(1.0%)的CA 19-9水平升高。多因素分析显示,年龄较大、女性、BMI较低和糖尿病是CA 19-9水平升高的独立易感因素。亚组分析显示,351名受试者中有129名(36.8%)的致病原因得以明确。其中,31名受试者(8.8%,包括4例癌症和15例良性肿瘤)的致病原因在初次检查时未被发现,而是在随访期间发现的。

结论

将CA 19-9用作健康个体癌症标志物是不合适的。然而,对CA 19-9水平升高的个体进行医学随访可能是有用的,因为在随访期间可能会发现一些致病疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9924/6768838/b67a8db39d6d/kjfm-18-0057f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9924/6768838/b67a8db39d6d/kjfm-18-0057f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9924/6768838/b67a8db39d6d/kjfm-18-0057f1.jpg

相似文献

1
Usefulness of Carbohydrate Antigen 19-9 Test in Healthy People and Necessity of Medical Follow-up in Individuals with Elevated Carbohydrate Antigen 19-9 Level.糖类抗原19-9检测在健康人群中的效用以及糖类抗原19-9水平升高个体进行医学随访的必要性。
Korean J Fam Med. 2019 Sep;40(5):314-322. doi: 10.4082/kjfm.18.0057. Epub 2019 Apr 8.
2
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.基于LOCI™技术的肿瘤标志物检测法对妇科癌症中肿瘤标志物CA 15-3、CA 125、癌胚抗原(CEA)、CA 19-9和甲胎蛋白(AFP)的临床检测性能
Tumour Biol. 2017 Oct;39(10):1010428317730246. doi: 10.1177/1010428317730246.
3
Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.乳腺癌患者术后随访及非恶性疾病中循环CA 15-3水平
Breast Cancer Res Treat. 1989 Mar;13(2):123-33. doi: 10.1007/BF01806524.
4
Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes.CA19-9 对新发糖尿病患者胰腺癌筛查的作用。
Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):263-268. doi: 10.1016/j.hbpd.2018.04.001. Epub 2018 Apr 20.
5
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population.碳水化合物抗原19-9作为无症状人群胰腺癌筛查试验的临床实用性。
J Gastroenterol Hepatol. 2004 Feb;19(2):182-6. doi: 10.1111/j.1440-1746.2004.03219.x.
6
Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.膀胱切除术前血清中糖类抗原19-9、糖类抗原125和癌胚抗原水平:对浸润性膀胱尿路上皮癌的预后价值
Urol Oncol. 2014 Jul;32(5):648-56. doi: 10.1016/j.urolonc.2014.01.019. Epub 2014 Mar 26.
7
Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.循环性乳腺癌标志物癌相关抗原CA - 549的血清水平及生化特性
Cancer Res. 1987 Nov 15;47(22):5853-60.
8
Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer.膀胱尿路上皮癌新辅助化疗后膀胱切除术前上皮肿瘤标志物反应与肿瘤学结局之间的关联
Urol Oncol. 2019 Jan;37(1):1-11. doi: 10.1016/j.urolonc.2018.09.008. Epub 2018 Nov 20.
9
Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China.中国大型健康体检队列中升高的癌抗原 19-9 浓度研究。
Clin Chem Lab Med. 2013 Jul;51(7):1459-66. doi: 10.1515/cclm-2012-0458.
10
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.术前 CEA 和 CA 19-9 是可切除性胰腺导管腺癌患者生存的预后标志物——一项回顾性肿瘤标志物预后研究。
Int J Surg. 2013;11(10):1067-72. doi: 10.1016/j.ijsu.2013.10.005. Epub 2013 Oct 23.

引用本文的文献

1
A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals.一种用于检测高危个体早期胰腺导管腺癌的高效生物标志物特征。
Cancers (Basel). 2025 Jun 2;17(11):1866. doi: 10.3390/cancers17111866.
2
Lung Adenocarcinoma Presenting With Elevated Serum Carbohydrate Antigen 19-9 Levels: A Case Report.血清糖类抗原19-9水平升高的肺腺癌:一例报告
Cureus. 2025 Jan 21;17(1):e77786. doi: 10.7759/cureus.77786. eCollection 2025 Jan.
3
Pancreatic incidentaloma: incidental findings from history towards the era of liquid biopsy.

本文引用的文献

1
Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes.CA19-9 对新发糖尿病患者胰腺癌筛查的作用。
Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):263-268. doi: 10.1016/j.hbpd.2018.04.001. Epub 2018 Apr 20.
2
Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer.血清肿瘤标志物在复发性胰腺癌检测中作用的系统评价
HPB (Oxford). 2018 Apr;20(4):297-304. doi: 10.1016/j.hpb.2017.11.009. Epub 2018 Feb 1.
3
Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.
胰腺偶发瘤:从病史中的偶然发现到液体活检时代
eGastroenterology. 2024 Sep 9;2(3):e100082. doi: 10.1136/egastro-2024-100082. eCollection 2024 Sep.
4
Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer.卵巢癌治疗策略中用于检测和靶向微小RNA/表观遗传学的不断演变的格局。
Cancer Lett. 2024 Nov 29;611:217357. doi: 10.1016/j.canlet.2024.217357.
5
Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.血清肿瘤标志物对住院治疗的间质性肺疾病急性加重患者的预后价值。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241250332. doi: 10.1177/17534666241250332.
6
Attitudes and health behaviors of middle-aged and older adults with elevated tumor markers in China.中国肿瘤标志物升高的中老年人的态度和健康行为。
Front Psychol. 2024 Feb 6;15:1265648. doi: 10.3389/fpsyg.2024.1265648. eCollection 2024.
7
Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study.中国成年人循环中糖类抗原19-9水平与2型糖尿病肾病的关联:一项横断面研究
Diabetes Metab Syndr Obes. 2024 Jan 31;17:467-477. doi: 10.2147/DMSO.S434972. eCollection 2024.
8
The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults.健康成年人中碳水化合物抗原(CA)19-9 水平与低骨骼肌质量的关联。
Nutrients. 2023 Jul 30;15(15):3394. doi: 10.3390/nu15153394.
9
The significance of elevated tumor markers among patients with interstitial lung diseases.肿瘤标志物升高对间质性肺疾病患者的意义。
Sci Rep. 2022 Oct 6;12(1):16702. doi: 10.1038/s41598-022-20683-w.
10
Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma.糖类抗原19-9作为肝外胆管癌的一种新型预后生物标志物。
World J Gastrointest Surg. 2021 Sep 27;13(9):1025-1038. doi: 10.4240/wjgs.v13.i9.1025.
血清癌胚抗原和糖类抗原19-9水平与结直肠肿瘤的存在及严重程度相关。
Yonsei Med J. 2017 Sep;58(5):918-924. doi: 10.3349/ymj.2017.58.5.918.
4
Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.使用多种肿瘤标志物对无症状人群进行癌症筛查。
PLoS One. 2016 Jun 29;11(6):e0158285. doi: 10.1371/journal.pone.0158285. eCollection 2016.
5
Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis.肿瘤标志物CA19-9、CA242和CEA在胰腺癌诊断中的Meta分析
Int J Clin Exp Med. 2015 Jul 15;8(7):11683-91. eCollection 2015.
6
CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.糖类抗原19-9在附件包块评估中的应用:回顾性队列分析及文献综述
Int J Biol Markers. 2015 Jul 22;30(3):e333-40. doi: 10.5301/jbm.5000139.
7
Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.糖尿病、吸烟、饮酒及癌症家族史作为胰腺神经内分泌肿瘤的危险因素:一项系统评价和荟萃分析
Neuroendocrinology. 2015;101(2):133-42. doi: 10.1159/000375164. Epub 2015 Jan 22.
8
Elevated serum CA 19-9 at screening tests: underlying conditions and role of abdominopelvic CT.筛查试验中血清CA 19-9升高:潜在病因及腹盆腔CT的作用
Eur Radiol. 2014 Oct;24(10):2435-48. doi: 10.1007/s00330-014-3262-2. Epub 2014 Aug 12.
9
Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China.中国大型健康体检队列中升高的癌抗原 19-9 浓度研究。
Clin Chem Lab Med. 2013 Jul;51(7):1459-66. doi: 10.1515/cclm-2012-0458.
10
The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.新发糖尿病与胰腺癌风险的关系:一项病例对照研究。
Eur J Cancer. 2011 Jan;47(2):248-54. doi: 10.1016/j.ejca.2010.07.010. Epub 2010 Aug 13.